Home
About
Product
magNews
Career
Contact Us
中文
English
Search News
Corporate
Industry
Technology
Medical Updates
extracorporeal ventricular assist device
Medical Updates
Bedside Echo-Guided Implantation of MoyoAssist® as a Bridge to Heart Transplantation
2025-08-20
Medical Updates
Successful Application of MoyoAssist® in Bridging to Long-Term LVAD
2025-04-09
Corporate
Redefining New Boundaries in Delivering Patient Care
2025-01-24
Industry
magAssist Showcases Next-Generation MCS Technologies at ISMCS 2024
2024-11-21
Medical Updates
MoyoAssist® Extra-VAD Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China
2024-06-28
Corporate
MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held
2024-06-24
Corporate
NMPA grants approval to MoyoAssist® China's first full maglev extracorporeal VAD
2024-05-14
Industry
Dr. Po-Lin Hsu from magAssist: Nothing is More Important than Saving Lives
2022-12-21
Corporate
Dr. Po-Lin Hsu Named on List of Forbes China - 100 Outstanding Overseas Returnees
2022-12-14
Medical Updates
The FIRST transseptal cannulation treatment via MoyoAssist Extra-VAD
2022-08-24
1
2
3
4
5
1/5
》
Tabs:
artificial organs,
interventional therapy,
Percutaneous VAD,
life support in case of multi-organ failure,
a short-term full maglev ventricular assist device,
critical care life support scenarios,
minimally-invasive,
How Artificial Heart Works,
a leading company in treating heart failures,
short-term bridging heart transplant patients,
Conference,
TOP